nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—GSTO1—osteoarthritis	0.00729	0.00729	CbGpPWpGaD
Amlexanox—IL3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.00689	0.00689	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—COL9A2—osteoarthritis	0.00681	0.00681	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.0068	0.0068	CbGpPWpGaD
Amlexanox—IL3—Hematopoietic Stem Cell Differentiation—IL6—osteoarthritis	0.00665	0.00665	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—COL9A1—osteoarthritis	0.00661	0.00661	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—CAMK2B—osteoarthritis	0.0065	0.0065	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—MCF2L—osteoarthritis	0.00646	0.00646	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.00638	0.00638	CbGpPWpGaD
Amlexanox—IL3—Interleukin-2 signaling—IL6—osteoarthritis	0.00585	0.00585	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—IGF1—osteoarthritis	0.00583	0.00583	CbGpPWpGaD
Amlexanox—IL3—Differentiation Pathway—IL6—osteoarthritis	0.00575	0.00575	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—MCF2L—osteoarthritis	0.00565	0.00565	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00547	0.00547	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00525	0.00525	CbGpPWpGaD
Amlexanox—IL3—Signaling by Interleukins—IL1B—osteoarthritis	0.00513	0.00513	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—MCF2L—osteoarthritis	0.00513	0.00513	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IHH—osteoarthritis	0.00513	0.00513	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00487	0.00487	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.00459	0.00459	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00428	0.00428	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00421	0.00421	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—HSPA5—osteoarthritis	0.00408	0.00408	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00408	0.00408	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TIMP1—osteoarthritis	0.00389	0.00389	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—MMP9—osteoarthritis	0.00386	0.00386	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00375	0.00375	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CTSK—osteoarthritis	0.0037	0.0037	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—MCF2L—osteoarthritis	0.00362	0.00362	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events triggered by IGF1R—IGF1—osteoarthritis	0.00356	0.00356	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—TGFB1—osteoarthritis	0.00349	0.00349	CbGpPWpGaD
Amlexanox—FGF1—IGF1R signaling cascade—IGF1—osteoarthritis	0.00346	0.00346	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IHH—osteoarthritis	0.00329	0.00329	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MCF2L—osteoarthritis	0.00329	0.00329	CbGpPWpGaD
Amlexanox—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.00322	0.00322	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—MCF2L—osteoarthritis	0.00315	0.00315	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00307	0.00307	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IHH—osteoarthritis	0.00303	0.00303	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MCF2L—osteoarthritis	0.00303	0.00303	CbGpPWpGaD
Amlexanox—IL3—Signaling by Interleukins—IL6—osteoarthritis	0.003	0.003	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—MCF2L—osteoarthritis	0.003	0.003	CbGpPWpGaD
Amlexanox—S100A12—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.00292	0.00292	CbGpPWpGaD
Amlexanox—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.00289	0.00289	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MCF2L—osteoarthritis	0.00286	0.00286	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IHH—osteoarthritis	0.00286	0.00286	CbGpPWpGaD
Amlexanox—S100A12—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.00284	0.00284	CbGpPWpGaD
Amlexanox—FGF1—FRS2-mediated cascade—IL6—osteoarthritis	0.00282	0.00282	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—MCF2L—osteoarthritis	0.00277	0.00277	CbGpPWpGaD
Amlexanox—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.00274	0.00274	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MCF2L—osteoarthritis	0.00272	0.00272	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IHH—osteoarthritis	0.00272	0.00272	CbGpPWpGaD
Amlexanox—IL3—Immune System—CAMK2B—osteoarthritis	0.00269	0.00269	CbGpPWpGaD
Amlexanox—IL3—Immune System—CTSK—osteoarthritis	0.00269	0.00269	CbGpPWpGaD
Amlexanox—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.00269	0.00269	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—FN1—osteoarthritis	0.00269	0.00269	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—ESR1—osteoarthritis	0.00268	0.00268	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—IL6—osteoarthritis	0.00263	0.00263	CbGpPWpGaD
Amlexanox—S100A12—MyD88-independent cascade—IL6—osteoarthritis	0.00258	0.00258	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00253	0.00253	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MCF2L—osteoarthritis	0.00252	0.00252	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IHH—osteoarthritis	0.00252	0.00252	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—MMP1—osteoarthritis	0.00242	0.00242	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00236	0.00236	CbGpPWpGaD
Amlexanox—S100A12—Activated TLR4 signalling—IL6—osteoarthritis	0.00232	0.00232	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00225	0.00225	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00223	0.00223	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—COL9A2—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Amlexanox—FGF1—Disease—FMOD—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—FN1—osteoarthritis	0.00221	0.00221	CbGpPWpGaD
Amlexanox—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	0.00218	0.00218	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—COL9A1—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CAMK2B—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTSK—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.00214	0.00214	CbGpPWpGaD
Amlexanox—IL3—Immune System—HSPA5—osteoarthritis	0.00214	0.00214	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTSK—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1RN—osteoarthritis	0.00208	0.00208	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CTSK—osteoarthritis	0.00203	0.00203	CbGpPWpGaD
Amlexanox—FGF1—Disease—IHH—osteoarthritis	0.00198	0.00198	CbGpPWpGaD
Amlexanox—S100A12—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IHH—osteoarthritis	0.00194	0.00194	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MCF2L—osteoarthritis	0.00194	0.00194	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IGF1—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00179	0.00179	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—MMP3—osteoarthritis	0.00174	0.00174	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CRP—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HSPA5—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IHH—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MCF2L—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1RN—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Amlexanox—FGF1—IRS-mediated signalling—IL6—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events—IL6—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HSPA5—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MCF2L—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IHH—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0016	0.0016	CbGpPWpGaD
Amlexanox—FGF1—Insulin receptor signalling cascade—IL6—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Amlexanox—FGF1—IGF1R signaling cascade—IL6—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1A—osteoarthritis	0.0015	0.0015	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MCF2L—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IHH—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—BMP2—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFBI—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—COL9A2—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MCF2L—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IHH—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—COL9A1—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—IL6—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Amlexanox—FGF1—Disease—GSTO1—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Amlexanox—IL3—Immune System—CRP—osteoarthritis	0.00125	0.00125	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—COL9A2—osteoarthritis	0.00124	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Disease—BGN—osteoarthritis	0.00124	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTSK—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CAMK2B—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—COL9A1—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1A—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—COL9A2—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TGFB1—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—COL9A1—osteoarthritis	0.00115	0.00115	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MMP3—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—IL6—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—COL9A2—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—COL9A1—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—IL6—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP3—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—COL9A2—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CRP—osteoarthritis	0.001	0.001	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—osteoarthritis	0.001	0.001	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—osteoarthritis	0.000995	0.000995	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—osteoarthritis	0.00099	0.00099	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—COL9A1—osteoarthritis	0.000989	0.000989	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CRP—osteoarthritis	0.000986	0.000986	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—osteoarthritis	0.000985	0.000985	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCL8—osteoarthritis	0.000983	0.000983	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HSPA5—osteoarthritis	0.000981	0.000981	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MMP3—osteoarthritis	0.000968	0.000968	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1RN—osteoarthritis	0.000954	0.000954	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BMP2—osteoarthritis	0.000948	0.000948	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMAD3—osteoarthritis	0.000928	0.000928	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—osteoarthritis	0.000927	0.000927	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000927	0.000927	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—osteoarthritis	0.000927	0.000927	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MMP3—osteoarthritis	0.000921	0.000921	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—osteoarthritis	0.000919	0.000919	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.00091	0.00091	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—osteoarthritis	0.000906	0.000906	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCL8—osteoarthritis	0.000892	0.000892	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MMP3—osteoarthritis	0.000853	0.000853	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BMP2—osteoarthritis	0.000825	0.000825	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000821	0.000821	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—LEP—osteoarthritis	0.000793	0.000793	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BMP2—osteoarthritis	0.000785	0.000785	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—osteoarthritis	0.000782	0.000782	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ESR1—osteoarthritis	0.000757	0.000757	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FN1—osteoarthritis	0.000748	0.000748	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BMP2—osteoarthritis	0.000727	0.000727	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1A—osteoarthritis	0.000687	0.000687	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BMP2—osteoarthritis	0.000678	0.000678	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP3—osteoarthritis	0.000657	0.000657	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1—osteoarthritis	0.000655	0.000655	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—osteoarthritis	0.000631	0.000631	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—osteoarthritis	0.00063	0.00063	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL8—osteoarthritis	0.00063	0.00063	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—osteoarthritis	0.000627	0.000627	CbGpPWpGaD
Amlexanox—FGF1—Disease—SMAD3—osteoarthritis	0.000607	0.000607	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMAD3—osteoarthritis	0.000595	0.000595	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—osteoarthritis	0.000574	0.000574	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP3—osteoarthritis	0.000572	0.000572	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL8—osteoarthritis	0.000572	0.000572	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL8—osteoarthritis	0.000548	0.000548	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP3—osteoarthritis	0.000544	0.000544	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL8—osteoarthritis	0.000527	0.000527	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL8—osteoarthritis	0.000522	0.000522	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMAD3—osteoarthritis	0.000518	0.000518	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—osteoarthritis	0.000508	0.000508	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP3—osteoarthritis	0.000504	0.000504	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—osteoarthritis	0.000501	0.000501	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL8—osteoarthritis	0.000498	0.000498	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMAD3—osteoarthritis	0.000493	0.000493	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ESR1—osteoarthritis	0.000485	0.000485	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—osteoarthritis	0.000483	0.000483	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FN1—osteoarthritis	0.000479	0.000479	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—osteoarthritis	0.000477	0.000477	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—osteoarthritis	0.000474	0.000474	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP3—osteoarthritis	0.00047	0.00047	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—osteoarthritis	0.000458	0.000458	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMAD3—osteoarthritis	0.000456	0.000456	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—osteoarthritis	0.000438	0.000438	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMAD3—osteoarthritis	0.000425	0.000425	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ESR1—osteoarthritis	0.000422	0.000422	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—osteoarthritis	0.000421	0.000421	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—osteoarthritis	0.00042	0.00042	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FN1—osteoarthritis	0.000417	0.000417	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ESR1—osteoarthritis	0.000402	0.000402	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FN1—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—osteoarthritis	0.000393	0.000393	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—osteoarthritis	0.00039	0.00039	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ESR1—osteoarthritis	0.000372	0.000372	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FN1—osteoarthritis	0.000367	0.000367	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—osteoarthritis	0.000367	0.000367	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—osteoarthritis	0.000366	0.000366	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—osteoarthritis	0.000363	0.000363	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—osteoarthritis	0.00036	0.00036	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—osteoarthritis	0.000348	0.000348	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ESR1—osteoarthritis	0.000347	0.000347	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FN1—osteoarthritis	0.000343	0.000343	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—osteoarthritis	0.000338	0.000338	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—osteoarthritis	0.000322	0.000322	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—osteoarthritis	0.000321	0.000321	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—osteoarthritis	0.000305	0.000305	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—osteoarthritis	0.0003	0.0003	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—osteoarthritis	0.000296	0.000296	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—osteoarthritis	0.000294	0.000294	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—osteoarthritis	0.000266	0.000266	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—osteoarthritis	0.000266	0.000266	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—osteoarthritis	0.000259	0.000259	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—osteoarthritis	0.000257	0.000257	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—osteoarthritis	0.000253	0.000253	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—osteoarthritis	0.000252	0.000252	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—osteoarthritis	0.000246	0.000246	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—osteoarthritis	0.000241	0.000241	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—osteoarthritis	0.000234	0.000234	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—osteoarthritis	0.000219	0.000219	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—osteoarthritis	0.00021	0.00021	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—osteoarthritis	0.000209	0.000209	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—osteoarthritis	0.000194	0.000194	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—osteoarthritis	0.000193	0.000193	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—osteoarthritis	0.00019	0.00019	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—osteoarthritis	0.00018	0.00018	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—osteoarthritis	0.000165	0.000165	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—osteoarthritis	0.000157	0.000157	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—osteoarthritis	0.000145	0.000145	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
